Zydus Lifesciences Limited (ZYDUSLIFE) — Insider Trading | 24 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Promoter member receives inherited shares via transmission
💡 Investor Takeaway
This increases the promoter's direct holding in the company.

Zydus Lifesciences disclosed that Prashant Patel of the promoter group received 32,577 shares via transmission from his late mother Jasodaben Patel, as per SEBI PIT Regulation 7(2) filing dated August 21, 2026.

📄 View Original Announcement (PDF)

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,15,919.92 Cr P/E: 25.9 ROE: 16.6% ROCE: 16.8% Div Yield: 0.09%

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZYDUSLIFE — Free

Free account · 2 AI queries/day